Personal data believed stolen in cyberattack at pharma company

Malaysian pharmaceutical company Duopharma Biotech Bhd has fallen victim to a cyberattack, according to preliminary investigations. The company disclosed that an unauthorized access attempt was detected by its cybersecurity systems, potentially resulting in the removal of certain data files, which could include personal information. Despite the security breach, Duopharma reassured the public that its core business operations remain unaffected, and all corporate activities continue to function as usual.

The company's internal cyber defense system identified the unauthorized system access attempt and swiftly implemented containment protocols. Consequently, the core corporate network and internal operational systems remain secure and operational. Duopharma is committed to collaborating with internal and external cybersecurity experts to conduct a thorough digital forensic investigation, aiming to determine the extent of the files compromised.

To ensure heightened security measures, the company will review its current cybersecurity environment and implement additional measures as necessary. At present, the company does not anticipate any financial implications stemming from the cyberattack. However, they are diligently assessing the impact as more information becomes available throughout the investigation process.

Should the investigation reveal the theft of personal data, Duopharma Biotech Bhd will promptly notify the Personal Data Protection Commissioner within the stipulated timeframe. The company, which specializes in the manufacturing and marketing of over 300 generic drugs, including popular over-the-counter products such as vitamin supplements and painkillers, reported that its share price closed at RM1.22 on the stock exchange today.